Main Topic - anti-NGF study in osteoarthrosis
- Brown MT, Murphy FT, Radin DM, Davignon I, Smith MD, West CR. Tanezumab reduces osteoarthritic hip pain: Results of a randomized, double-blind, placebo-controlled phase 3 trial. Arthritis Rheum 2013.
- Mechanism of action of tanezumab
- FDA independent review of rapidly progressive osteoarthritis with anti-NGF agents
- Womac disease activity score